ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 143 out of 783

$697K Total Retail Price of All Prescriptions

Rank: 138 out of 783

634 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

30% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 452 220 S3 1 2
FUROSEMIDE 414 291 2 7
AMLODIPINE BESYLATE 379 303 3 5
LISINOPRIL 305 204 4 4
SIMVASTATIN 264 202 5 3
LEVOTHYROXINE SODIUM 251 218 6 1
METOPROLOL TARTRATE 251 200 6 9
METOPROLOL SUCCINATE 249 197 8 13
OMEPRAZOLE 225 142 9 6
POTASSIUM CHLORIDE 206 171 10 16
METFORMIN HCL 196 112 11 8
GABAPENTIN 172 119 12 15
WARFARIN SODIUM 163 100 13 10
PANTOPRAZOLE SODIUM 152 127 14 30
TRAMADOL HCL 128 97 15 20
FAMOTIDINE 123 78 16 55
ZOLPIDEM TARTRATE 117 84 17 23
GLIMEPIRIDE 116 84 18 34
ATORVASTATIN CALCIUM 109 86 19 11
KLOR-CON M20 107 57 20 48
CARVEDILOL 101 62 21 21
DIGOXIN 97 86 22 61
PROAIR HFA 92 48 23 56
DONEPEZIL HCL 90 83 24 24
CLONIDINE HCL 90 54 24 60
TRAZODONE HCL 89 49 26 39
ATENOLOL 88 57 27 17
SPIRONOLACTONE 86 49 28 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 62 29 33
CLOPIDOGREL 85 56 29 29
ADVAIR DISKUS 80 50 31 50
SPIRIVA 78 57 32 59
CRESTOR 78 54 32 27
NAMENDA 76 63 34 32
OXYBUTYNIN CHLORIDE 73 51 35 96
SERTRALINE HCL 71 66 36 22
NEXIUM 70 26 37 28
HYDROCHLOROTHIAZIDE 69 47 38 12
MIRTAZAPINE 66 62 39 52
PEN NEEDLE 62 32 40 103
LANTUS 62 41 40 38
TRIAMTERENE-HCTZ 61 44 42 42
TIZANIDINE HCL 60 30 43 133
PLAVIX 60 45 43 51
ENALAPRIL MALEATE 60 43 43 68
MELOXICAM 60 22 43 37
ESCITALOPRAM OXALATE 59 43 47 54
NIFEDIPINE ER 59 43 47 135
TAMSULOSIN HCL 58 43 49 26
PREDNISONE 58 36 49 36
CYMBALTA 57 37 51 35
CIPROFLOXACIN HCL 56 39 52 62
AMOX TR-POTASSIUM CLAVULANATE 56 29 52 128
BENAZEPRIL HCL 55 48 54 85
HYDRALAZINE HCL 54 33 55 78
SUBOXONE 53 0 56 255
LOSARTAN-HYDROCHLOROTHIAZIDE 51 33 57 53
FLUOXETINE HCL 50 29 58 45
ALPRAZOLAM 50 43 58 145
PHENYTOIN SODIUM EXTENDED 50 35 58 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.